Urological Devices | Market Insights | US | 2025
Fueled by product innovation, rising kidney stone prevalence, and an aging population, the US market for urological devices will grow at a moderate rate through 2033, driven particularly by rising revenues for BPH devices—especially Aquablation—single-use endoscopes, and UI devices. Other contributing factors for growth include an increasing prevalence of obesity, the adoption of premium devices, and the growing availability of less-invasive treatment options.
This Medtech 360 Report provides comprehensive data and analysis on the state of the US urological device market from 2019 through 2033.
